Search

everythinglearnresearchcommunity

for

Search:↓

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Frontalis suspension surgery using autologous fascia lata is effective for treating unilateral congenital ptosis with poor levator function.

Certain eye surgery complications can be managed effectively, especially in patients who have used specific prostate medications.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

The triple rotation scalp flap technique successfully reconstructed a man's scalp with natural-looking hair growth and minimal scarring.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

About 61% of women who had COVID-19 experienced hair loss afterward.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Non-Kuwaitis with COVID-19 had higher chances of severe outcomes than Kuwaitis.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

Androgenetic alopecia severity does not affect COVID-19 severity.

Hair loss doesn't affect COVID-19 severity.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Some vitamins, amino acids, and alternative medicines can cause serious side effects, including bone, muscle, and skin issues, and healthcare professionals should be aware of these risks.

Possible link between androgens and COVID-19 severity; more research needed.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.